Long-term maintenance of hemoglobin levels in hemodialysis patients treated with bi-weekly epoetin beta pegol switched from darbepoetin alfa: a single-center, 12-month observational study in Japan-Reference-Cited by-同舟云学术

Long-term maintenance of hemoglobin levels in hemodialysis patients treated with bi-weekly epoetin beta pegol switched from darbepoetin alfa: a single-center, 12-month observational study in Japan

Published:2018-11-14 Issue:2 Volume:22 Page:146-153
ISSN:1434-7229
Container-title:Journal of Artificial Organs
language:en
Short-container-title:J Artif Organs

Author:

Kawai Toru,Kusano Yoshie,Yamada Kyouko,Ueda Chikako,Kawai Atsushi,Masaki Takao

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Biomedical Engineering,Biomaterials,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s10047-018-1080-z.pdf

Reference31 articles.

1. Macdougal IC, Robson R, Opatrna S, et al. Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (CERA) in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2006;1:1211–5.

2. De Cock E, Kritikou P, Ravera S, et al. Time savings with once-monthly C.E.R.A.: a time and motion study conducted in 13 haemodialysis centres in Italy. Blood Purif. 2015;40:173–9.

3. Onuma S, Honda H, Kobayashi Y, et al. Effects of long-term erythropoiesis-stimulating agents on iron metabolism in patients on hemodialysis. Ther Apher Dial. 2015;19:582–9.

4. Locatelli F, Choukroun G, Truman M, et al. Once-monthly continuous erythropoietin receptor activator (C.E.R.A.) in patients with hemodialysis-dependent chronic kidney disease: pooled data from phase III trials. Adv Ther. 2016;33:610–25.

5. Sulowicz W, Locatelli F, Ryckelynck JP, et al. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly. Clin J Am Soc Nephrol. 2007;2:637–46.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleiotropic effect of erythropoiesis-stimulating agents on circulating endothelial progenitor cells in dialysis patients;Clinical and Experimental Nephrology;2021-06-09

2. NON-STEROIDAL HUMAN PERFORMANCE ENHANCING AGENTS;INDIAN DRUGS;2021-04-20

3. Updates on Novel Erythropoiesis-Stimulating Agents: Clinical and Molecular Approach;Indian Journal of Hematology and Blood Transfusion;2019-09-16